Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | ONCO | ENVB | ||
| Company | Phasebio Pharmaceuticals Inc | Onconetix Inc | Enveric Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0800 | 2.40 | 6.23 | ||
| High | 0.0920 | 2.40 | 6.23 | ||
| Low | 0.0665 | 2.29 | 5.35 | ||
| Latest | 0.0701 | 2.30 | 5.43 | ||
| Change | -0.0249 | -0.01 | -0.01 | ||
| % Change | -26.21% | -0.43% | -0.18% | ||
| Volume | 9,647,400 | 46,800 | 294,000 | ||
| 20-Day Average Volume | 3,930,150 | 38,260 | 2,026,520 | ||
| Previous Close | 0.0950 | 2.31 | 5.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 2.52 | 6.02 | ||
| 20-Day Raw Stochastic | 2.27% | 17.85% | 6.57% | ||
| 20-Day Relative Strength | 20.88 | 42.14 | 45.54 | ||
| Weighted Alpha | -91.26 | -87.60 | -84.44 | ||
| Today's Opinion | 100% Sell | 100% Sell | 96% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 96% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | -10.68% since 12/05/25 | -20.03% since 12/05/25 | ||
| Low | 0.0665 on 11/02/22 | 2.29 on 12/12/25 | 5.05 on 12/11/25 | ||
| High | 0.1440 on 10/27/22 | 3.22 on 12/10/25 | 13.25 on 12/10/25 | ||
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -16.36% since 11/12/25 | -9.20% since 11/12/25 | ||
| Low | 0.0665 on 11/02/22 | 2.10 on 11/18/25 | 4.88 on 11/17/25 | ||
| High | 0.2250 on 10/14/22 | 3.22 on 12/10/25 | 13.25 on 12/10/25 | ||
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -24.59% since 09/12/25 | -53.35% since 09/12/25 | ||
| Low | 0.0665 on 11/02/22 | 2.10 on 11/18/25 | 4.88 on 11/17/25 | ||
| High | 1.3800 on 08/09/22 | 4.19 on 10/09/25 | 13.25 on 12/10/25 | ||
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | -63.48% since 06/12/25 | -63.51% since 06/12/25 | ||
| Low | 0.0665 on 11/02/22 | 2.10 on 11/18/25 | 4.88 on 11/17/25 | ||
| High | 1.3800 on 08/09/22 | 5.93 on 06/13/25 | 17.64 on 08/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 3,590 | 3,242 | ||
| Shares Outstanding, K | 49,858 | 1,561 | 597 | ||
| Annual Sales | 10,830,000 | 2,520,000 | 0 | ||
| Annual Net Income | -131,070,000 | -58,690,000 | -9,570,000 | ||
| Last Quarter Sales | 210,000 | 300,000 | 0 | ||
| Last Quarter Net Income | -16,670,000 | -8,780,000 | -1,870,000 | ||
| 60-Month Beta | 2.57 | 3.42 | 0.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | -6.25 on 11/13/25 | -10.81 on 11/14/25 | ||
| Latest Earnings Date | 11/09/22 | 06/01/26 | 03/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||